




Searching News Database: ImmunoGen
HSMN NewsFeed - 31 Jan 2025
U.S. FDA Approves Celltrion's AVTOZMA(R) (tocilizumab-anoh), a Biosimilar to ACTEMRA(R)
U.S. FDA Approves Celltrion's AVTOZMA(R) (tocilizumab-anoh), a Biosimilar to ACTEMRA(R)
HSMN NewsFeed - 3 Apr 2024
Kintara Therapeutics and TuHURA Biosciences Enter into Definitive Merger Agreement
Kintara Therapeutics and TuHURA Biosciences Enter into Definitive Merger Agreement
HSMN NewsFeed - 21 Feb 2024
AbbVie Announces Appointment of Robert A. Michael as Chief Executive Officer
AbbVie Announces Appointment of Robert A. Michael as Chief Executive Officer
HSMN NewsFeed - 7 Sep 2023
enGene Appoints Richard Bryce, MBChB, MRCGP, MFPM, as Chief Medical Officer
enGene Appoints Richard Bryce, MBChB, MRCGP, MFPM, as Chief Medical Officer
HSMN NewsFeed - 3 Aug 2023
Kyverna Therapeutics Extends Series B Financing Round to $145 Million and Brings in New Investors
Kyverna Therapeutics Extends Series B Financing Round to $145 Million and Brings in New Investors
HSMN NewsFeed - 9 Jan 2023
Boehringer Ingelheim and 3T Biosciences Join Forces to Develop Next-Generation Cancer Immunotherapies
Boehringer Ingelheim and 3T Biosciences Join Forces to Develop Next-Generation Cancer Immunotherapies
HSMN NewsFeed - 16 May 2022
Promontory Therapeutics Appoints Johan Baeck, MD, as Executive Vice President and Chief Medical Officer
Promontory Therapeutics Appoints Johan Baeck, MD, as Executive Vice President and Chief Medical Officer
HSMN NewsFeed - 5 May 2022
Phosplatin Therapeutics Adopts New Corporate Name as Promontory Therapeutics Inc.
Phosplatin Therapeutics Adopts New Corporate Name as Promontory Therapeutics Inc.
HSMN NewsFeed - 30 Aug 2021
Laronde Attracts $440M in First External Financing to Further Advance Endless RNA(TM) Platform
Laronde Attracts $440M in First External Financing to Further Advance Endless RNA(TM) Platform
HSMN NewsFeed - 19 Jan 2021
Lilly and Merus NV Announce Collaboration to Discover Novel T-Cell Re-Directing Bispecific Antibodies
Lilly and Merus NV Announce Collaboration to Discover Novel T-Cell Re-Directing Bispecific Antibodies
HSMN NewsFeed - 7 Oct 2020
Lilly provides comprehensive update on progress of SARS-CoV-2 neutralizing antibody programs
Lilly provides comprehensive update on progress of SARS-CoV-2 neutralizing antibody programs
HSMN NewsFeed - 23 Sep 2020
Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen's COVID-19 Vaccine Candidate
Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen's COVID-19 Vaccine Candidate
HSMN NewsFeed - 3 Jul 2020
IDELVION(R) Becomes First and Only Factor IX Therapy with 21-Day Prophylactic Dosing
IDELVION(R) Becomes First and Only Factor IX Therapy with 21-Day Prophylactic Dosing
HSMN NewsFeed - 8 Jun 2020
Lilly Announces Start of a Phase 1 Study for its Second Potential COVID-19 Antibody Treatment
Lilly Announces Start of a Phase 1 Study for its Second Potential COVID-19 Antibody Treatment
HSMN NewsFeed - 4 Jun 2020
Mylan and Lupin Receive European Marketing Authorization for Nepexto(R), Biosimilar Etanercept
Mylan and Lupin Receive European Marketing Authorization for Nepexto(R), Biosimilar Etanercept
HSMN NewsFeed - 15 May 2020
Soligenix Announces Recent Accomplishments And First Quarter 2020 Financial Results
Soligenix Announces Recent Accomplishments And First Quarter 2020 Financial Results
HSMN NewsFeed - 19 Mar 2020
BiondVax's CEO Comments on Impact of COVID-19 Pandemic on the Company's Ongoing Phase 3 Clinical Trial
BiondVax's CEO Comments on Impact of COVID-19 Pandemic on the Company's Ongoing Phase 3 Clinical Trial
HSMN NewsFeed - 24 Oct 2019
Amgen To Make Repatha(R) (evolocumab) Available Exclusively At Its Lower List Price Option In 2020
Amgen To Make Repatha(R) (evolocumab) Available Exclusively At Its Lower List Price Option In 2020
HSMN NewsFeed - 28 Jun 2019
Amgen and UCB Provide Regulatory Update on Status of EVENITY(TM) (romosozumab) in the EU
Amgen and UCB Provide Regulatory Update on Status of EVENITY(TM) (romosozumab) in the EU
HSMN NewsFeed - 13 Mar 2019
Alvotech Enrolls First Patient in Clinical Phase III Study Involving Biosimilar Version of HUMIRA(R)
Alvotech Enrolls First Patient in Clinical Phase III Study Involving Biosimilar Version of HUMIRA(R)
HSMN NewsFeed - 3 Dec 2018
Neurelis Announces Acquisition Of Aegis Therapeutics, A Leading Drug Delivery Technology Company
Neurelis Announces Acquisition Of Aegis Therapeutics, A Leading Drug Delivery Technology Company
HSMN NewsFeed - 19 Oct 2018
Mylan and Biocon Announce Positive CHMP Opinion for Ogivri(R), Biosimilar Trastuzumab
Mylan and Biocon Announce Positive CHMP Opinion for Ogivri(R), Biosimilar Trastuzumab
HSMN NewsFeed - 14 Aug 2018
BiondVax Receives Second €6M Tranche Disbursement From the European Investment Bank (EIB)
BiondVax Receives Second €6M Tranche Disbursement From the European Investment Bank (EIB)
HSMN NewsFeed - 28 Jun 2018
Corporate Biotech Executive Mark Germain Joins BiondVax's Board of Directors
Corporate Biotech Executive Mark Germain Joins BiondVax's Board of Directors
HSMN NewsFeed - 18 Jun 2018
Mallinckrodt Reports Interim Findings Of H.P. Acthar(R) Gel (Repository Corticotropin Injection) Studies
Mallinckrodt Reports Interim Findings Of H.P. Acthar(R) Gel (Repository Corticotropin Injection) Studies
HSMN NewsFeed - 8 Jun 2018
European Commission Approves Prolia(R) (denosumab) for Patients With Glucocorticoid-Induced Osteoporosis
European Commission Approves Prolia(R) (denosumab) for Patients With Glucocorticoid-Induced Osteoporosis
HSMN NewsFeed - 20 Apr 2018
FDA Accepts Veloxis's Supplemental New Drug Application for the De Novo Indication for ENVARSUS XR(R)
FDA Accepts Veloxis's Supplemental New Drug Application for the De Novo Indication for ENVARSUS XR(R)
HSMN NewsFeed - 11 Apr 2018
Genprex Appoints Julien Pham, MD, MPH As President To Lead Commercialization Of Oncoprex Immunogene Therapy
Genprex Appoints Julien Pham, MD, MPH As President To Lead Commercialization Of Oncoprex Immunogene Therapy
HSMN NewsFeed - 27 Feb 2018
Amgen Receives Positive CHMP Opinion For Delivery System Of Neulasta(R) (pegfilgrastim)
Amgen Receives Positive CHMP Opinion For Delivery System Of Neulasta(R) (pegfilgrastim)
HSMN NewsFeed - 10 Jan 2018
BYDUREON(R) BCise(TM) Injectable Medicine Now Available In The US For Patients With Type-2 Diabetes
BYDUREON(R) BCise(TM) Injectable Medicine Now Available In The US For Patients With Type-2 Diabetes
HSMN NewsFeed - 3 Jan 2018
Agenus Announces Key Leadership to Advance Combination Trials For Planned BLA Filings
Agenus Announces Key Leadership to Advance Combination Trials For Planned BLA Filings
HSMN NewsFeed - 1 Dec 2017
FDA approves first biosimilar for the treatment of certain breast and stomach cancers
FDA approves first biosimilar for the treatment of certain breast and stomach cancers
HSMN NewsFeed - 8 Sep 2017
Replimune Raises $55 Million to Advance its Oncolytic Immunotherapy Programs
Replimune Raises $55 Million to Advance its Oncolytic Immunotherapy Programs
HSMN NewsFeed - 21 Jul 2017
EMA's CHMP Issues Positive Opinion for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma
EMA's CHMP Issues Positive Opinion for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma
HSMN NewsFeed - 22 Feb 2017
Repatha(R) (Evolocumab) Receives European Commission Approval For New 420 mg Single-Dose Delivery Option
Repatha(R) (Evolocumab) Receives European Commission Approval For New 420 mg Single-Dose Delivery Option
HSMN NewsFeed - 16 Jan 2017
European Commission Amends Marketing Authorisation for RUCONEST(R) to Include Self-Administration
European Commission Amends Marketing Authorisation for RUCONEST(R) to Include Self-Administration
HSMN NewsFeed - 27 Dec 2016
Shire Announces FDA Approval of Adynovate(R) for use in Children and Surgical Settings
Shire Announces FDA Approval of Adynovate(R) for use in Children and Surgical Settings
HSMN NewsFeed - 7 Dec 2016
Neovacs obtains FDA “Fast Track” designation for IFNα Kinoid in Lupus (SLE)
Neovacs obtains FDA “Fast Track” designation for IFNα Kinoid in Lupus (SLE)
HSMN NewsFeed - 14 Nov 2016
First Patient Enrolled in Mallinckrodt Phase 4 Trial of H.P. Acthar(R) Gel for Rheumatoid Arthritis
First Patient Enrolled in Mallinckrodt Phase 4 Trial of H.P. Acthar(R) Gel for Rheumatoid Arthritis
HSMN NewsFeed - 11 Nov 2016
CHMP Adopts Positive Opinion to Include Self-administration for RUCONEST(R)
CHMP Adopts Positive Opinion to Include Self-administration for RUCONEST(R)
HSMN NewsFeed - 1 Nov 2016
Pfizer Discontinues Global Development of Bococizumab, Its Investigational PCSK9 Inhibitor
Pfizer Discontinues Global Development of Bococizumab, Its Investigational PCSK9 Inhibitor
HSMN NewsFeed - 30 May 2016
FLIXABI(R), Biogen’s Infliximab Biosimilar Referencing Remicade(R), Approved in the European Union
FLIXABI(R), Biogen’s Infliximab Biosimilar Referencing Remicade(R), Approved in the European Union
HSMN NewsFeed - 25 Jan 2016
BioLineRx Receives Confirmation of Medical Device Classification in Europe for Celiac Treatment
BioLineRx Receives Confirmation of Medical Device Classification in Europe for Celiac Treatment
HSMN NewsFeed - 17 Jan 2016
BENEPALI(R), the First Etanercept Biosimilar Referencing Enbrel(R), Approved in the European Union
BENEPALI(R), the First Etanercept Biosimilar Referencing Enbrel(R), Approved in the European Union
HSMN NewsFeed - 16 Oct 2015
Johnson & Johnson Announces Start of Clinical Trial of Ebola Vaccine Regimen in Sierra Leone
Johnson & Johnson Announces Start of Clinical Trial of Ebola Vaccine Regimen in Sierra Leone
HSMN NewsFeed - 27 Aug 2015
Immuno-Oncology Veteran Rachel Humphrey, M.D., Joins CytomX as Chief Medical Officer
Immuno-Oncology Veteran Rachel Humphrey, M.D., Joins CytomX as Chief Medical Officer
HSMN NewsFeed - 21 Jul 2015
Dauntless Pharmaceuticals and Aegis Therapeutics Announce Licensing Agreement
Dauntless Pharmaceuticals and Aegis Therapeutics Announce Licensing Agreement
HSMN NewsFeed - 25 Jun 2015
Aegerion Pharmaceuticals Appoints Gregory Perry as Chief Financial Officer
Aegerion Pharmaceuticals Appoints Gregory Perry as Chief Financial Officer
HSMN NewsFeed - 1 Apr 2015
ImmunoGen, Inc. Appoints Anna Berkenblit, MD, MMSc Vice President and Chief Medical Officer
ImmunoGen, Inc. Appoints Anna Berkenblit, MD, MMSc Vice President and Chief Medical Officer
HSMN NewsFeed - 6 Jan 2015
CytomX Raises $20 Million in Series C Round Led by Pfizer Venture Investments
CytomX Raises $20 Million in Series C Round Led by Pfizer Venture Investments
HSMN NewsFeed - 12 Dec 2014
Sanofi Pasteur Announces FDA Approval of Fluzone(R) Intradermal Quadrivalent (Influenza Vaccine) for Adults
Sanofi Pasteur Announces FDA Approval of Fluzone(R) Intradermal Quadrivalent (Influenza Vaccine) for Adults
HSMN NewsFeed - 1 Dec 2014
Ascendis Pharma A/S Completes $60 million Oversubscribed Series D Financing
Ascendis Pharma A/S Completes $60 million Oversubscribed Series D Financing
HSMN NewsFeed - 23 Sep 2014
Soligenix Appoints Rasappa Arumugham, PhD, as Vice President of Biopharmaceutical Development
Soligenix Appoints Rasappa Arumugham, PhD, as Vice President of Biopharmaceutical Development
HSMN NewsFeed - 18 Sep 2014
NOXXON Pharma Expands Management Team by Appointing Don Munoz as Chief Financial Officer
NOXXON Pharma Expands Management Team by Appointing Don Munoz as Chief Financial Officer
HSMN NewsFeed - 21 Aug 2014
Galena Biopharma Appoints Mark W. Schwartz, Ph.D., as President and Chief Executive Officer
Galena Biopharma Appoints Mark W. Schwartz, Ph.D., as President and Chief Executive Officer
HSMN NewsFeed - 11 Jun 2014
Lilly Announces Top-Line Results Of Phase III Hepatocellular Carcinoma Trial
Lilly Announces Top-Line Results Of Phase III Hepatocellular Carcinoma Trial
HSMN NewsFeed - 31 Jan 2014
ImmunoGen, Inc. Appoints Eric Guempel as Vice President of Product Strategy and Program Management
ImmunoGen, Inc. Appoints Eric Guempel as Vice President of Product Strategy and Program Management
HSMN NewsFeed - 20 Nov 2013
ImmunoGen, Inc. Announces Approval of Roche’s Kadcyla(R) in the European Union
ImmunoGen, Inc. Announces Approval of Roche’s Kadcyla(R) in the European Union
HSMN NewsFeed - 21 Oct 2013
Soligenix Announces Appointment of Marco Maria Brughera to its Board of Directors
Soligenix Announces Appointment of Marco Maria Brughera to its Board of Directors
HSMN NewsFeed - 3 Oct 2013
Soligenix Appoints Oreola Donini, PhD, as Vice President of Preclinical Research and Development
Soligenix Appoints Oreola Donini, PhD, as Vice President of Preclinical Research and Development
HSMN NewsFeed - 16 Sep 2013
FDA Grants Soligenix Orphan Drug Designation for SGX94 for Treatment of Acute Radiation Syndrome
FDA Grants Soligenix Orphan Drug Designation for SGX94 for Treatment of Acute Radiation Syndrome
HSMN NewsFeed - 25 Feb 2013
Dynavax Receives FDA Complete Response Letter on HEPLISAV(TM) Biologic License Application
Dynavax Receives FDA Complete Response Letter on HEPLISAV(TM) Biologic License Application
HSMN NewsFeed - 3 Jan 2013
NewLink Genetics Appoints Mr. Brian Wiley as Vice President of Business Development
NewLink Genetics Appoints Mr. Brian Wiley as Vice President of Business Development
HSMN NewsFeed - 4 Dec 2012
Galena Biopharma Announces Signature of Commercialization Partnership With Teva for Israel
Galena Biopharma Announces Signature of Commercialization Partnership With Teva for Israel
HSMN NewsFeed - 2 Nov 2012
Vical Names Mammen P. Mammen, Jr., M.D., Vice President, Clinical Vaccines
Vical Names Mammen P. Mammen, Jr., M.D., Vice President, Clinical Vaccines
HSMN NewsFeed - 16 May 2012
Genentech Will Report New Data on Important Progress for People with Advanced Cancers at ASCO 2012
Genentech Will Report New Data on Important Progress for People with Advanced Cancers at ASCO 2012
HSMN NewsFeed - 3 May 2012
Genentech Reports Positive Study of ACTEMRA Given by Subcutaneous Injection
Genentech Reports Positive Study of ACTEMRA Given by Subcutaneous Injection
HSMN NewsFeed - 30 Jan 2012
ImmunoGen, Inc. Announces Addition of Kristine Peterson and Dean Mitchell to Its Board of Directors
ImmunoGen, Inc. Announces Addition of Kristine Peterson and Dean Mitchell to Its Board of Directors
HSMN NewsFeed - 7 Nov 2011
Nabi Biopharmaceuticals Announces Results of Second NicVAX(R) Phase III Clinical Trial
Nabi Biopharmaceuticals Announces Results of Second NicVAX(R) Phase III Clinical Trial
HSMN NewsFeed - 13 Sep 2011
Alvine Pharmaceuticals Appoints James D. Watson as Senior Vice President and Chief Business Officer
Alvine Pharmaceuticals Appoints James D. Watson as Senior Vice President and Chief Business Officer
HSMN NewsFeed - 2 Jun 2011
Soligenix Appoints Joseph Warusz as Vice President of Administration and Controller
Soligenix Appoints Joseph Warusz as Vice President of Administration and Controller
HSMN NewsFeed - 21 Mar 2011
Selventa Names John Tagliamonte as Senior Vice President of Corporate Development
Selventa Names John Tagliamonte as Senior Vice President of Corporate Development
HSMN NewsFeed - 18 Jan 2011
ImmunoGen, Inc. Appoints Theresa Wingrove, Ph.D., as Vice President, Regulatory Affairs
ImmunoGen, Inc. Appoints Theresa Wingrove, Ph.D., as Vice President, Regulatory Affairs
HSMN NewsFeed - 21 Sep 2010
Athersys Receives Orphan Drug Designation for MultiStem in Graft vs. Host Disease
Athersys Receives Orphan Drug Designation for MultiStem in Graft vs. Host Disease
HSMN NewsFeed - 8 Jun 2010
CryoLife Receives FDA 510(k) Clearance for CryoValve(R) SG Pulmonary Heart Valve Shelf-life Extension
CryoLife Receives FDA 510(k) Clearance for CryoValve(R) SG Pulmonary Heart Valve Shelf-life Extension
HSMN NewsFeed - 26 May 2010
Alvine Pharmaceuticals Announces Equity Investment by Abbott Biotech Ventures Inc.
Alvine Pharmaceuticals Announces Equity Investment by Abbott Biotech Ventures Inc.
HSMN NewsFeed - 6 May 2010
ThermoGenesis Names Leading Healthcare Industry Executive David Carter to Board of Directors
ThermoGenesis Names Leading Healthcare Industry Executive David Carter to Board of Directors
HSMN NewsFeed - 26 Jan 2010
Novo Nordisk's Victoza(R) Receives FDA Approval for Adults With Type 2 Diabetes
Novo Nordisk's Victoza(R) Receives FDA Approval for Adults With Type 2 Diabetes
HSMN NewsFeed - 17 Dec 2009
ImmunoGen, Inc. Appoints Suzanne Cadden as Vice President, Regulatory Affairs & Quality
ImmunoGen, Inc. Appoints Suzanne Cadden as Vice President, Regulatory Affairs & Quality
HSMN NewsFeed - 7 Oct 2009
Baxter Receives European Commission Approval for CELVAPAN H1N1 Pandemic Influenza Vaccine
Baxter Receives European Commission Approval for CELVAPAN H1N1 Pandemic Influenza Vaccine
HSMN NewsFeed - 29 Jun 2009
DOR BioPharma Announces Publication of orBec(R) Clinical Pulmonary Data in Bone Marrow Transplantation
DOR BioPharma Announces Publication of orBec(R) Clinical Pulmonary Data in Bone Marrow Transplantation
HSMN NewsFeed - 13 Mar 2009
DOR BioPharma Appoints Brian L. Hamilton, MD, PhD as Chief Medical Officer
DOR BioPharma Appoints Brian L. Hamilton, MD, PhD as Chief Medical Officer
HSMN NewsFeed - 5 Mar 2009
GlycoVaxyn AG Raises CHF 25 Million in Financing Led by Edmond de Rothschild Investment Partners
GlycoVaxyn AG Raises CHF 25 Million in Financing Led by Edmond de Rothschild Investment Partners
HSMN NewsFeed - 16 Feb 2009
AlphaVax Announces New Vice President of Regulatory, Quality and Clinical Operations
AlphaVax Announces New Vice President of Regulatory, Quality and Clinical Operations
HSMN NewsFeed - 19 Jan 2009
IBT Labs Adds Senior R&D, Marketing, and Sales Executives to Leadership Team
IBT Labs Adds Senior R&D, Marketing, and Sales Executives to Leadership Team
HSMN NewsFeed - 6 Jan 2009
DOR BioPharma Obtains Fast Track Designation for DOR201 in the Prevention of Acute Radiation Enteritis
DOR BioPharma Obtains Fast Track Designation for DOR201 in the Prevention of Acute Radiation Enteritis
HSMN NewsFeed - 22 Dec 2008
KaloBios Raises Additional $12 Million in Series D Venture Financing for a New Total of $32 Million
KaloBios Raises Additional $12 Million in Series D Venture Financing for a New Total of $32 Million
HSMN NewsFeed - 12 Aug 2008
ImmunoGen, Inc. Announces sanofi-aventis Licenses Expanded Access to the Company's TAP Technology
ImmunoGen, Inc. Announces sanofi-aventis Licenses Expanded Access to the Company's TAP Technology
HSMN NewsFeed - 11 Jun 2008
NOXXON Pharma AG Announces Licensing and Discovery Collaboration with Eli Lilly and Company
NOXXON Pharma AG Announces Licensing and Discovery Collaboration with Eli Lilly and Company
HSMN NewsFeed - 22 May 2008
DOR BioPharma Provides Update on orBec(R) European Regulatory and Development Strategy
DOR BioPharma Provides Update on orBec(R) European Regulatory and Development Strategy
HSMN NewsFeed - 14 May 2008
CERVARIX(R) Shown to Provide Longest Duration of Sustained Neutralizing Antibodies to Date
CERVARIX(R) Shown to Provide Longest Duration of Sustained Neutralizing Antibodies to Date
HSMN NewsFeed - 6 May 2008
Lev Pharmaceuticals Announces Cinryze(TM) Complete Response Submission Accepted for Review by FDA
Lev Pharmaceuticals Announces Cinryze(TM) Complete Response Submission Accepted for Review by FDA
HSMN NewsFeed - 24 Mar 2008
CryoLife Announces Implant of First FDA-Cleared SynerGraft(R) Processed Human Pulmonary Heart Valve
CryoLife Announces Implant of First FDA-Cleared SynerGraft(R) Processed Human Pulmonary Heart Valve
HSMN NewsFeed - 17 Mar 2008
Amgen and Wyeth Announce Updates to U.S. Prescribing Information for Enbrel(R)
Amgen and Wyeth Announce Updates to U.S. Prescribing Information for Enbrel(R)
HSMN NewsFeed - 10 Mar 2008
GSK Cervical Cancer Candidate Vaccine CERVARIX (R) Demonstrates Long-Term Protection for More Than Six Years
GSK Cervical Cancer Candidate Vaccine CERVARIX (R) Demonstrates Long-Term Protection for More Than Six Years
HSMN NewsFeed - 7 Feb 2008
CryoLife Receives FDA 510(k) Clearance for SynerGraft(R) Processed Human Pulmonary Heart Valves
CryoLife Receives FDA 510(k) Clearance for SynerGraft(R) Processed Human Pulmonary Heart Valves
HSMN NewsFeed - 29 Jan 2008
KaloBios Strengthens Development Expertise With Additions to Senior Management Team
KaloBios Strengthens Development Expertise With Additions to Senior Management Team
HSMN NewsFeed - 20 Dec 2007
Nektar Announces Agreement With Baxter to Develop New PEGylated Therapeutics for Hemophilia
Nektar Announces Agreement With Baxter to Develop New PEGylated Therapeutics for Hemophilia
HSMN NewsFeed - 7 Dec 2007
DOR BioPharma Announces Results of orBec(R) End of Review Conference With the FDA
DOR BioPharma Announces Results of orBec(R) End of Review Conference With the FDA
HSMN NewsFeed - 6 Dec 2007
Favrille to Report New Data on FavId (Now Specifid) at American Society of Hematology Annual Meeting
Favrille to Report New Data on FavId (Now Specifid) at American Society of Hematology Annual Meeting
HSMN NewsFeed - 27 Nov 2007
ImmunoGen, Inc. Hires John Tagliamonte as Vice President, Business Development
ImmunoGen, Inc. Hires John Tagliamonte as Vice President, Business Development
HSMN NewsFeed - 12 Nov 2007
VaxGen and Raven biotechnologies Announce Signing of Definitive Merger Agreement
VaxGen and Raven biotechnologies Announce Signing of Definitive Merger Agreement
HSMN NewsFeed - 19 Oct 2007
Sanofi Pasteur Receives FDA Approval of Meningococcal Vaccine for Children
Sanofi Pasteur Receives FDA Approval of Meningococcal Vaccine for Children
HSMN NewsFeed - 9 Oct 2007
orBec(R) Clinical Summary Published in "Expert Opinion on Investigational Drugs"
orBec(R) Clinical Summary Published in "Expert Opinion on Investigational Drugs"
HSMN NewsFeed - 3 Oct 2007
ImmunoGen, Inc. Hires Craig Barrows as Vice President, General Counsel and Secretary
ImmunoGen, Inc. Hires Craig Barrows as Vice President, General Counsel and Secretary
HSMN NewsFeed - 21 Sep 2007
Vectibix(TM) (panitumumab) Receives Positive Opinion for Marketing Authorization in the European Union
Vectibix(TM) (panitumumab) Receives Positive Opinion for Marketing Authorization in the European Union
HSMN NewsFeed - 20 Sep 2007
Vical Licensee Sanofi-aventis Initiates Phase 3 Trial to Reduce Amputations
Vical Licensee Sanofi-aventis Initiates Phase 3 Trial to Reduce Amputations
HSMN NewsFeed - 19 Sep 2007
Dynavax's HEPLISAV(TM) Hepatitis B Vaccine Maintains Full Immunogenicity at 50 Weeks in Phase 3 Trial
Dynavax's HEPLISAV(TM) Hepatitis B Vaccine Maintains Full Immunogenicity at 50 Weeks in Phase 3 Trial
HSMN NewsFeed - 10 Sep 2007
Lev Pharmaceuticals Meets Primary Endpoint in Pivotal Phase III Prophylactic Trial for Hereditary Angioedema
Lev Pharmaceuticals Meets Primary Endpoint in Pivotal Phase III Prophylactic Trial for Hereditary Angioedema
HSMN NewsFeed - 29 Jun 2007
Mymetics Expands Board of Directors with the Addition of Dr. Thomas Staehelin
Mymetics Expands Board of Directors with the Addition of Dr. Thomas Staehelin
HSMN NewsFeed - 11 Jun 2007
Archemix and Takeda to Enter into Collaboration for Discovery and Development of Aptamer Therapeutics
Archemix and Takeda to Enter into Collaboration for Discovery and Development of Aptamer Therapeutics
HSMN NewsFeed - 3 Jun 2007
Oxford Biomedica and Sanofi-Aventis Report new TroVax(R) Phase II Trial Results in Renal Cancer
Oxford Biomedica and Sanofi-Aventis Report new TroVax(R) Phase II Trial Results in Renal Cancer
HSMN NewsFeed - 14 May 2007
Former Immunex Management Team Chosen to Head-Up CTI Subsidiary Aequus BioPharma, Inc.
Former Immunex Management Team Chosen to Head-Up CTI Subsidiary Aequus BioPharma, Inc.
HSMN NewsFeed - 11 May 2007
Mersana Therapeutics, Inc. Announces the Appointment of Robert J. Fram, M.D. as Chief Medical Officer
Mersana Therapeutics, Inc. Announces the Appointment of Robert J. Fram, M.D. as Chief Medical Officer
HSMN NewsFeed - 9 May 2007
FDA Advisory Panel Reviews DOR BioPharma's orBec(R) for Treatment of GI GVHD
FDA Advisory Panel Reviews DOR BioPharma's orBec(R) for Treatment of GI GVHD
HSMN NewsFeed - 4 Apr 2007
DOR BioPharma Announces Initiation of Clinical Development Program for Oral Leuprolide
DOR BioPharma Announces Initiation of Clinical Development Program for Oral Leuprolide
HSMN NewsFeed - 20 Feb 2007
Gerard McGarrity Joins VIRxSYS as Executive Vice President of Scientific and Clinical Affairs
Gerard McGarrity Joins VIRxSYS as Executive Vice President of Scientific and Clinical Affairs
HSMN NewsFeed - 12 Feb 2007
AVANT Immunotherapeutics and Select Vaccines Announce Partnership to Develop Improved Viral Vaccines
AVANT Immunotherapeutics and Select Vaccines Announce Partnership to Develop Improved Viral Vaccines
HSMN NewsFeed - 31 Jan 2007
FDA Advisory Committee to Review DOR BioPharma's orBec(R) for the Treatment of GI GVHD
FDA Advisory Committee to Review DOR BioPharma's orBec(R) for the Treatment of GI GVHD
HSMN NewsFeed - 24 Jan 2007
Vical Highlights Transition to Phase 3 Trial With Allovectin-7(R) for Metastatic Melanoma
Vical Highlights Transition to Phase 3 Trial With Allovectin-7(R) for Metastatic Melanoma
HSMN NewsFeed - 17 Jan 2007
Archemix and Merck KGaA to Collaborate on Aptamer-Based Cancer Therapeutics
Archemix and Merck KGaA to Collaborate on Aptamer-Based Cancer Therapeutics
HSMN NewsFeed - 17 Jan 2007
GlaxoSmithKline Awarded $63 Million HHS Contract for Pandemic Vaccine Research and Development
GlaxoSmithKline Awarded $63 Million HHS Contract for Pandemic Vaccine Research and Development
HSMN NewsFeed - 4 Jan 2007
Vical Initiates Pivotal Phase 3 Trial of Allovectin-7(R) as First-line Therapy for Metastatic Melanoma
Vical Initiates Pivotal Phase 3 Trial of Allovectin-7(R) as First-line Therapy for Metastatic Melanoma
HSMN NewsFeed - 28 Nov 2006
European Medicines Agency Accepts DOR BioPharma's MAA Filing for orBec(R)
European Medicines Agency Accepts DOR BioPharma's MAA Filing for orBec(R)
HSMN NewsFeed - 8 Nov 2006
Halozyme Therapeutics Names William Fallon Vice President, Manufacturing & Operations
Halozyme Therapeutics Names William Fallon Vice President, Manufacturing & Operations
HSMN NewsFeed - 7 Nov 2006
DOR BioPharma Submits European Marketing Application for orBec(R) to Treat GI Graft-Versus-Host Disease
DOR BioPharma Submits European Marketing Application for orBec(R) to Treat GI Graft-Versus-Host Disease
HSMN NewsFeed - 6 Nov 2006
Geron Licenses Antigen Targeting Patents for Cancer Vaccine Program from Immunomic Therapeutics
Geron Licenses Antigen Targeting Patents for Cancer Vaccine Program from Immunomic Therapeutics
HSMN NewsFeed - 1 Nov 2006
Carrington's DelSite Subsidiary Presents Data on Needle-Free Vaccine Technology
Carrington's DelSite Subsidiary Presents Data on Needle-Free Vaccine Technology
HSMN NewsFeed - 26 Oct 2006
Arrowhead Subsidiary, Insert Therapeutics, Inc., Raises $10 Million in Private Equity Financing
Arrowhead Subsidiary, Insert Therapeutics, Inc., Raises $10 Million in Private Equity Financing
HSMN NewsFeed - 16 Oct 2006
OMRIX Biopharmaceuticals Announces Positive Phase 3 Clinical Trial Results for Human Thrombin
OMRIX Biopharmaceuticals Announces Positive Phase 3 Clinical Trial Results for Human Thrombin
HSMN NewsFeed - 12 Oct 2006
Arrowhead Subsidiary, Insert Therapeutics, to Hire Pharmaceutical Executive as Chief Executive Officer
Arrowhead Subsidiary, Insert Therapeutics, to Hire Pharmaceutical Executive as Chief Executive Officer
HSMN NewsFeed - 3 Oct 2006
Archemix Strengthens Management With Appointment of James Gilbert, M.D., as Chief Medical Officer
Archemix Strengthens Management With Appointment of James Gilbert, M.D., as Chief Medical Officer
HSMN NewsFeed - 2 Oct 2006
PowderMed to Conduct U.S. Clinical Trial of DNA-Based Annual Influenza Vaccine
PowderMed to Conduct U.S. Clinical Trial of DNA-Based Annual Influenza Vaccine
HSMN NewsFeed - 29 Sep 2006
Amgen to Acquire Avidia, a Privately Held Biopharmaceutical Company in the San Francisco Bay Area
Amgen to Acquire Avidia, a Privately Held Biopharmaceutical Company in the San Francisco Bay Area
HSMN NewsFeed - 22 Sep 2006
DOR BioPharma Files New Drug Application with FDA to Market orBec for GI GVHD
DOR BioPharma Files New Drug Application with FDA to Market orBec for GI GVHD
HSMN NewsFeed - 13 Jul 2006
Nastech Pharmaceutical Company Receives FDA Communication Concerning Calcitonin-Salmon Nasal Spray
Nastech Pharmaceutical Company Receives FDA Communication Concerning Calcitonin-Salmon Nasal Spray
HSMN NewsFeed - 7 Jul 2006
Nektar and University of Alabama in Huntsville Announce Agreement to Settle Litigation
Nektar and University of Alabama in Huntsville Announce Agreement to Settle Litigation
HSMN NewsFeed - 6 Jul 2006
Ortec Issues Update on Its Three Technology Platforms for Regenerative Medicine and Stem Cells
Ortec Issues Update on Its Three Technology Platforms for Regenerative Medicine and Stem Cells
HSMN NewsFeed - 27 Jun 2006
Halozyme and Baxter Announce Availability of Hylenex for Subcutaneous Delivery of Medications and Fluids
Halozyme and Baxter Announce Availability of Hylenex for Subcutaneous Delivery of Medications and Fluids
HSMN NewsFeed - 21 Jun 2006
First AdNectin Therapeutic, CT-322, Clears FDA IND Review to Start Clinical Trials
First AdNectin Therapeutic, CT-322, Clears FDA IND Review to Start Clinical Trials
HSMN NewsFeed - 1 Jun 2006
Ablynx Strengthens Management Team - Eva-Lotta Allan Joins as Chief Business Officer
Ablynx Strengthens Management Team - Eva-Lotta Allan Joins as Chief Business Officer
HSMN NewsFeed - 31 May 2006
Archemix Corp. Strengthens its Board of Directors Adding Alnylam President and CEO, John Maraganore, Ph.D.
Archemix Corp. Strengthens its Board of Directors Adding Alnylam President and CEO, John Maraganore, Ph.D.
HSMN NewsFeed - 23 May 2006
Halozyme Therapeutics Announces FDA 510(k) Clearance for MediCult's SynVitro Cumulase Product
Halozyme Therapeutics Announces FDA 510(k) Clearance for MediCult's SynVitro Cumulase Product
HSMN NewsFeed - 22 May 2006
Cook Features Surgisis ES: New Product for the Treatment of Penile Curvature
Cook Features Surgisis ES: New Product for the Treatment of Penile Curvature
HSMN NewsFeed - 4 May 2006
ImmunoGen, Inc. to Develop Commercial-Scale Manufacturing Process for Trastuzumab-DM1 for Genentech
ImmunoGen, Inc. to Develop Commercial-Scale Manufacturing Process for Trastuzumab-DM1 for Genentech
Additional items found! 224

Members Archive contains
224 additional stories matching:
ImmunoGen
(Password required)
ImmunoGen
(Password required)